💡
Innocrat
Innovation Rules The World
Sign In
NanoGuard Drug Delivery Capsule
1 / 1
℗ Pending
Verified

NanoGuard Drug Delivery Capsule

pH-triggered nano-capsule that releases chemotherapy drugs only inside tumour cells.

Healthcare
Available For
License
Innovation Stage
Clinical Trial
IP Type
Pending
Views
821
104
Interested Buyers
104

people are interested

Why should this innovation interest you?

Problem Being Solved

Systemic chemotherapy damages healthy tissue causing severe side-effects and low efficacy.

Key Advantages

Tumour selectivity >98% in Phase-I murine trials
Biodegrades within 72 h post-drug-release—no residue toxicity

🔍About the Innovation

🏠 Problem

Systemic chemotherapy damages healthy tissue causing severe side-effects and low efficacy.

💡 Solution

Lipid-polymer hybrid nanocapsules with tumour-microenvironment pH sensors (6.5 threshold).

⭐Key Features

✓Tumour selectivity >98% in Phase-I murine trials
✓Biodegrades within 72 h post-drug-release—no residue toxicity
Usage: Oncology, targeted antibiotic delivery, gene therapy vectors.

Intellectual Property

IP TypePatent
IP StatusPending
Patent NumberIN202341067890

₹Commercial Information

Available ForLicense
Expected Value₹25 Lakh
NegotiableNo
Royalty ModelYes
Royalty %6.00
Min Deal Value₹2 Lakh

Looking for something specific?

Let our experts help you find the right innovation for your business.

Talk to Innocrat Team →